BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15882879)

  • 1. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
    Kapoor S; Pal S; Sahni P; Dattagupta S; Kanti Chattopadhyay T
    J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine as adjuvant treatment in colorectal cancer.
    Nielsen HJ; Christensen IJ; Moesgaard F; Kehlet H;
    Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative short course famotidine on TILs and survival in breast cancer.
    Parshad R; Hazrah P; Kumar S; Gupta SD; Ray R; Bal S
    Indian J Cancer; 2005; 42(4):185-90. PubMed ID: 16391436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group.
    Langman MJ; Dunn JA; Whiting JL; Burton A; Hallissey MT; Fielding JW; Kerr DJ
    Br J Cancer; 1999 Dec; 81(8):1356-62. PubMed ID: 10604733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-incisional infiltration for pediatric tonsillectomy: a randomized double-blind clinical trial.
    Naja MZ; El-Rajab M; Kabalan W; Ziade MF; Al-Tannir MA
    Int J Pediatr Otorhinolaryngol; 2005 Oct; 69(10):1333-41. PubMed ID: 16159655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes.
    Kelly MD; King J; Cherian M; Dwerryhouse SJ; Finlay IG; Adams WJ; King DW; Lubowski DZ; Morris DL
    Cancer; 1999 Apr; 85(8):1658-63. PubMed ID: 10223557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.
    Lucas BD; Williams MA; Mohiuddin SM; LaMadrid LJ; Schroeder LJ; Hilleman DE
    Pharmacotherapy; 1998; 18(4):824-30. PubMed ID: 9692655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor proliferation and apoptosis after preoperative hepatic and regional arterial infusion chemotherapy in prevention of liver metastasis after colorectal cancer surgery].
    Zhong YS; Lü SX; Xu JM
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(16):1229-33. PubMed ID: 19094597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
    Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
    Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
    Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
    Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
    Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
    Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.